Therapy/Class: Corticosteroid
Mechanism of Action:
Loteprednol Etabonate: A retrometabolic, ester-based ‘soft’ corticosteroid structurally designed to provide potent localized immunosuppressive and anti-inflammatory effects, followed by predictable, rapid de-esterification into inactive carboxylic acid metabolites. This mechanism dramatically mitigates the propensity for steroid-induced intraocular pressure (IOP) elevation.